The developmental pathways to schizophrenia: Potential moderating effects of stress

被引:31
作者
Walker, EF [1 ]
Neumann, CC [1 ]
Baum, K [1 ]
Davis, DM [1 ]
DiForio, D [1 ]
Bergman, A [1 ]
机构
[1] MISSISSIPPI STATE UNIV, MISSISSIPPI STATE, MS 39762 USA
关键词
D O I
10.1017/S0954579400007343
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
The observations of family members as well as the results of past research suggest that a variety of developmental pathways can precede the onset of schizophrenia in early adulthood. In this article, we describe recent findings from our research on the childhood precursors of schizophrenia. Taken together, the results indicate that childhood behavioral, emotional, and motoric dysfunction occur at a higher rare in preschizophrenia subjects when compared to control subjects. Further, there are developmental changes as well as significant variability among schizophrenia patients in the nature and severity of childhood impairment. Drawing on the prevailing diathesis-stress model, we explore the moderating role that stress exposure and reactivity may play in the expression of the organic diathesis for schizophrenia. Specifically, we consider the role of the biological stress response in the production of developmental changes and individual differences in the pathways to schizophrenia. Given extant models of dopamine involvement in the neuropathology of schizophrenia, stress-induced cortisol release may alter the expression of subcortical abnormalities in dopamine neurotransmission. Thus, we present a neural mechanism for the hypothesized behavioral sensitivity to stress exposure in schizophrenia, and explore the capacity of the model to account for the changing behavioral manifestations of vulnerability.
引用
收藏
页码:647 / 665
页数:19
相关论文
共 126 条
[11]   THE EFFECTS OF METABOLIC STRESS ON PLASMA PROGESTERONE IN HEALTHY-VOLUNTEERS AND SCHIZOPHRENIC-PATIENTS [J].
BREIER, A ;
BUCHANAN, RW .
LIFE SCIENCES, 1992, 51 (19) :1527-1534
[12]   CLOZAPINE ATTENUATES META-CHLOROPHENYLPIPERAZINE (MCPP)-INDUCED PLASMA-CORTISOL INCREASES IN SCHIZOPHRENIA [J].
BREIER, A ;
KIRKPATRICK, B ;
BUCHANAN, RW .
BIOLOGICAL PSYCHIATRY, 1993, 34 (07) :492-494
[13]   SUB-SYNDROMES OF TARDIVE-DYSKINESIA AND SOME CLINICAL CORRELATES [J].
BROWN, KW ;
WHITE, T .
PSYCHOLOGICAL MEDICINE, 1992, 22 (04) :923-927
[14]   CORTISOL IN ALCOHOLICS WITH A DISORDERED AGGRESSION CONTROL [J].
BUYDENSBRANCHEY, L ;
BRANCHEY, MH .
PSYCHONEUROENDOCRINOLOGY, 1992, 17 (01) :45-54
[15]   CENTRAL ADMINISTRATION OF CORTICOTROPIN RELEASING-FACTOR INDUCES LONG-TERM SENSITIZATION TO D-AMPHETAMINE [J].
CADOR, M ;
COLE, BJ ;
KOOB, GF ;
STINUS, L ;
LEMOAL, M .
BRAIN RESEARCH, 1993, 606 (02) :181-186
[16]  
Caligiuri M P, 1990, J Neuropsychiatry Clin Neurosci, V2, P395
[17]  
CANNON TD, 1990, ARCH GEN PSYCHIAT, V47, P622
[18]   THE SCHIZOPHRENIA HIGH-RISK PROJECT IN COPENHAGEN - 3 DECADES OF PROGRESS [J].
CANNON, TD ;
MEDNICK, SA .
ACTA PSYCHIATRICA SCANDINAVICA, 1993, 87 :33-47
[19]   TREATMENT OF NEGATIVE SYMPTOMS [J].
CARPENTER, WT ;
HEINRICHS, DW ;
ALPHS, LD .
SCHIZOPHRENIA BULLETIN, 1985, 11 (03) :440-452
[20]  
CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578